Interactions of allelic variance of PNPLA3 with nongenetic factors in predicting nonalcoholic steatohepatitis and nonhepatic complications of severe obesity
Maureen M. J. Guichelaar(Mayo Clinic), Michael Charlton(Madrigal Pharmaceuticals (United States)), Kimberly Viker(Mayo Clinic), Michael Malinchoc(Statistics Austria), Michael Olivier(Wake Forest University), Michael G. Sarr(Mayo Clinic), Arunkumar Krishnan(West Virginia University), Schuyler O. Sanderson(Mayo Clinic), K.D.S. Watt(Mayo Clinic), J. Swain(Mayo Clinic), Samer Gawrieh(Indiana University School of Medicine)
Cited by 29
Related Papers
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Journal of Hepatology|2023|2.7k
Bisphenol-A: an estrogenic substance is released from polycarbonate flasks during autoclaving.
|Endocrinology|1993|1.5k
Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease
|Gastroenterology|2015|799
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Annals of Hepatology|2023|789